David Kandzari, MD of the Piedmont Heart Institute in Atlanta, who has participated in the pre-clinical studies of stent deliverability offers, "My experience in the development and testing of this important new stent platform leads me to believe that it will offer the potential of a new standard in deliverability, due to the extremely thin struts, flexibility and low profile. Importantly, the stent has radiographic visibility and radial strength equivalent to much bulkier devices."
The new material allows a stent with strut thickness of 63 microns, a reduction of more than 20 percent versus the leading stents in use today. Dr. Antonio Colombo of Milan, Italy comments, "I have reviewed this new device and look forward to using it clinically, as it may offer a very strong advantage in enhanced visibility. In addition, the thin struts and excellent deliverability should lead to very favorable BMS clinical results."
ICON® is developing distribution and manufacturing options for commercial sale of the Nuloy Stent System in the European community.
About ICON Interventional Systems
ICON Interventional Systems® is an emerging medical device company developing next generation cardiovascular solutions for patients and doctors around the world. For more information visit http://www.icon-us.com.
Contact: Jack Merritt, President, 678-651-2319
ICON, the ICON Logo, Nuloy and MoRe are registered trademarks of ICON Medical Corp.
